You just read:

Daiichi Sankyo Europe and Esperion Announce Validation of the Marketing Authorisation Application (MAA) for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet

News provided by

Daiichi Sankyo Company, Limited

Feb 28, 2019, 07:00 ET